Excelsior Biopharma Inc. (6496.TWO)

TWD 30.0

(0.0%)

Total Liabilities Summary of Excelsior Biopharma Inc.

  • Excelsior Biopharma Inc.'s latest annual total liabilities in 2023 was 472.87 Million TWD , down -6.83% from previous year.
  • Excelsior Biopharma Inc.'s latest quarterly total liabilities in 2024 Q2 was 625.3 Million TWD , up 0.43% from previous quarter.
  • Excelsior Biopharma Inc. reported annual total liabilities of 507.53 Million TWD in 2022, down -16.65% from previous year.
  • Excelsior Biopharma Inc. reported annual total liabilities of 608.89 Million TWD in 2021, down -1.34% from previous year.
  • Excelsior Biopharma Inc. reported quarterly total liabilities of 625.3 Million TWD for 2024 Q2, up 0.43% from previous quarter.
  • Excelsior Biopharma Inc. reported quarterly total liabilities of 816.8 Million TWD for 2023 Q3, up 62.3% from previous quarter.

Annual Total Liabilities Chart of Excelsior Biopharma Inc. (2023 - 2019)

Historical Annual Total Liabilities of Excelsior Biopharma Inc. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 472.87 Million TWD -6.83%
2022 507.53 Million TWD -16.65%
2021 608.89 Million TWD -1.34%
2020 617.14 Million TWD 0.0%
2019 - TWD 0.0%

Peer Total Liabilities Comparison of Excelsior Biopharma Inc.

Name Total Liabilities Total Liabilities Difference
Allied Biotech Corporation 910.11 Million TWD 48.042%
GeneFerm Biotechnology Co., Ltd. 282.53 Million TWD -67.367%
Easywell Biomedicals, Inc. 589.98 Million TWD 19.85%
TTY Biopharm Company Limited 3.36 Billion TWD 85.963%
Synmosa Biopharma Corporation 3.62 Billion TWD 86.965%
Orient EuroPharma Co., Ltd. 6.64 Billion TWD 92.888%
Center Laboratories, Inc. 6.78 Billion TWD 93.032%
Tien Liang BioTech Co., Ltd. 161.05 Million TWD -193.616%
Orient Pharma Co., Ltd. 892.18 Million TWD 46.998%
InnoPharmax Inc. 48.64 Million TWD -872.012%
Johnson Chemical Pharmaceutical Works Co., Ltd. 320.99 Million TWD -47.316%
DV Biomed Co., Ltd. 765.87 Million TWD 38.257%
Foresee Pharmaceuticals Co., Ltd. 616.93 Million TWD 23.351%
Handa Pharmaceuticals, Inc. 280.88 Million TWD -68.354%
UniPharma Co., Ltd. 37.4 Million TWD -1164.335%
Anxo Pharmaceutical Co., Ltd. 1.01 Billion TWD 53.427%
Alar Pharmaceuticals Inc. 76.08 Million TWD -521.475%
Winston Medical Supply Co., Ltd. 373.87 Million TWD -26.479%
Mercury Biopharmaceutical Corporation 49.72 Million TWD -851.055%
Bioray Biotech Co., Ltd 108.75 Million TWD -334.819%
TSH Biopharm Corporation Limited 133.62 Million TWD -253.879%